Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.

BACKGROUND: It has been hypothesized that persistent hepatitis C virus (HCV) infection is mediated in part by viral proteins that abrogate the host immune response, including the complement system, but the precise mechanisms are not well understood. We investigated whether HCV proteins are involved...

Full description

Bibliographic Details
Main Authors: Seiichi Mawatari, Hirofumi Uto, Akio Ido, Kenji Nakashima, Tetsuro Suzuki, Shuji Kanmura, Kotaro Kumagai, Kohei Oda, Kazuaki Tabu, Tsutomu Tamai, Akihiro Moriuchi, Makoto Oketani, Yuko Shimada, Masayuki Sudoh, Ikuo Shoji, Hirohito Tsubouchi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3861371?pdf=render
id doaj-045de7e95e3b4de894a64d7ef4fb68db
record_format Article
spelling doaj-045de7e95e3b4de894a64d7ef4fb68db2020-11-24T21:54:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01812e8209410.1371/journal.pone.0082094Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.Seiichi MawatariHirofumi UtoAkio IdoKenji NakashimaTetsuro SuzukiShuji KanmuraKotaro KumagaiKohei OdaKazuaki TabuTsutomu TamaiAkihiro MoriuchiMakoto OketaniYuko ShimadaMasayuki SudohIkuo ShojiHirohito TsubouchiBACKGROUND: It has been hypothesized that persistent hepatitis C virus (HCV) infection is mediated in part by viral proteins that abrogate the host immune response, including the complement system, but the precise mechanisms are not well understood. We investigated whether HCV proteins are involved in the fragmentation of complement component 4 (C4), composed of subunits C4α, C4β, and C4γ, and the role of HCV proteins in complement activation. METHODS: Human C4 was incubated with HCV nonstructural (NS) 3/4A protease, core, or NS5. Samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then subjected to peptide sequencing. The activity of the classical complement pathway was examined using an erythrocyte hemolysis assay. The cleavage pattern of C4 in NS3/4A-expressing and HCV-infected cells, respectively, was also examined. RESULTS: HCV NS3/4A protease cleaved C4γ in a concentration-dependent manner, but viral core and NS5 did not. A specific inhibitor of NS3/4A protease reduced C4γ cleavage. NS3/4A protease-mediated cleavage of C4 inhibited classical pathway activation, which was abrogated by a NS3/4A protease inhibitor. In addition, co-transfection of cells with C4 and wild-type NS3/4A, but not a catalytic-site mutant of NS3/4A, produced cleaved C4γ fragments. Such C4 processing, with a concomitant reduction in levels of full-length C4γ, was also observed in HCV-infected cells expressing C4. CONCLUSIONS: C4 is a novel cellular substrate of the HCV NS3/4A protease. Understanding disturbances in the complement system mediated by NS3/4A protease may provide new insights into the mechanisms underlying persistent HCV infection.http://europepmc.org/articles/PMC3861371?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Seiichi Mawatari
Hirofumi Uto
Akio Ido
Kenji Nakashima
Tetsuro Suzuki
Shuji Kanmura
Kotaro Kumagai
Kohei Oda
Kazuaki Tabu
Tsutomu Tamai
Akihiro Moriuchi
Makoto Oketani
Yuko Shimada
Masayuki Sudoh
Ikuo Shoji
Hirohito Tsubouchi
spellingShingle Seiichi Mawatari
Hirofumi Uto
Akio Ido
Kenji Nakashima
Tetsuro Suzuki
Shuji Kanmura
Kotaro Kumagai
Kohei Oda
Kazuaki Tabu
Tsutomu Tamai
Akihiro Moriuchi
Makoto Oketani
Yuko Shimada
Masayuki Sudoh
Ikuo Shoji
Hirohito Tsubouchi
Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.
PLoS ONE
author_facet Seiichi Mawatari
Hirofumi Uto
Akio Ido
Kenji Nakashima
Tetsuro Suzuki
Shuji Kanmura
Kotaro Kumagai
Kohei Oda
Kazuaki Tabu
Tsutomu Tamai
Akihiro Moriuchi
Makoto Oketani
Yuko Shimada
Masayuki Sudoh
Ikuo Shoji
Hirohito Tsubouchi
author_sort Seiichi Mawatari
title Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.
title_short Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.
title_full Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.
title_fullStr Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.
title_full_unstemmed Hepatitis C virus NS3/4A protease inhibits complement activation by cleaving complement component 4.
title_sort hepatitis c virus ns3/4a protease inhibits complement activation by cleaving complement component 4.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description BACKGROUND: It has been hypothesized that persistent hepatitis C virus (HCV) infection is mediated in part by viral proteins that abrogate the host immune response, including the complement system, but the precise mechanisms are not well understood. We investigated whether HCV proteins are involved in the fragmentation of complement component 4 (C4), composed of subunits C4α, C4β, and C4γ, and the role of HCV proteins in complement activation. METHODS: Human C4 was incubated with HCV nonstructural (NS) 3/4A protease, core, or NS5. Samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then subjected to peptide sequencing. The activity of the classical complement pathway was examined using an erythrocyte hemolysis assay. The cleavage pattern of C4 in NS3/4A-expressing and HCV-infected cells, respectively, was also examined. RESULTS: HCV NS3/4A protease cleaved C4γ in a concentration-dependent manner, but viral core and NS5 did not. A specific inhibitor of NS3/4A protease reduced C4γ cleavage. NS3/4A protease-mediated cleavage of C4 inhibited classical pathway activation, which was abrogated by a NS3/4A protease inhibitor. In addition, co-transfection of cells with C4 and wild-type NS3/4A, but not a catalytic-site mutant of NS3/4A, produced cleaved C4γ fragments. Such C4 processing, with a concomitant reduction in levels of full-length C4γ, was also observed in HCV-infected cells expressing C4. CONCLUSIONS: C4 is a novel cellular substrate of the HCV NS3/4A protease. Understanding disturbances in the complement system mediated by NS3/4A protease may provide new insights into the mechanisms underlying persistent HCV infection.
url http://europepmc.org/articles/PMC3861371?pdf=render
work_keys_str_mv AT seiichimawatari hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT hirofumiuto hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT akioido hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT kenjinakashima hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT tetsurosuzuki hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT shujikanmura hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT kotarokumagai hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT koheioda hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT kazuakitabu hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT tsutomutamai hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT akihiromoriuchi hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT makotooketani hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT yukoshimada hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT masayukisudoh hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT ikuoshoji hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
AT hirohitotsubouchi hepatitiscvirusns34aproteaseinhibitscomplementactivationbycleavingcomplementcomponent4
_version_ 1725866449759633408